Fuller & Thaler Asset Management’s Pfizer PFE Stock Holding History

Fuller & Thaler Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-33,728	Closed	-$1.16M	–	660
2018 Q2	$1.16M	Hold	33,728	–	–	0.01%	322
2018 Q1	$1.14M	Sell	33,728 -25,612	-43%	-$880K	0.01%	315
2017 Q4	$2.04M	Hold	59,340	–	–	0.02%	261
2017 Q3	$2.01M	Sell	59,340 -18,867	-24%	-$606K	0.02%	246
2017 Q2	$2.49M	Hold	78,207	–	–	0.03%	204
2017 Q1	$2.54M	Buy	78,207 +27,826	+55%	+$877K	0.03%	194
2016 Q4	$1.55M	Hold	50,381	–	–	0.02%	222
2016 Q3	$1.62M	Buy	+50,381	New	+$1.68M	0.03%	212
2016 Q1	–	Sell	-13,800	Closed	-$423K	–	850
2015 Q4	$423K	Hold	13,800	–	–	0.01%	294
2015 Q3	$411K	Sell	13,800 -16,126	-54%	-$517K	0.01%	300
2015 Q2	$952K	Sell	29,926 -16,232	-35%	-$529K	0.03%	262
2015 Q1	$1.52M	Sell	46,158 -5,164	-10%	-$164K	0.05%	237
2014 Q4	$1.52M	Buy	51,322 +737	+1%	+$21.1K	0.05%	230
2014 Q3	$1.42M	Sell	50,585 -18,550	-27%	-$521K	0.06%	241
2014 Q2	$1.95M	Buy	69,135 +1,792	+3%	+$51.1K	0.08%	217
2014 Q1	$2.05M	Sell	67,343 -5,270	-7%	-$157K	0.1%	207
2013 Q4	$2.11M	Hold	72,613	–	–	0.12%	197
2013 Q3	$1.98M	Buy	72,613 +24,242	+50%	+$660K	0.12%	210
2013 Q2	$1.28M	Buy	+48,371	New	+$1.34M	0.09%	233

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fuller & Thaler Asset Management's PFE Position: Q3 2018 in Review

Fuller & Thaler Asset Management sold out of Pfizer (PFE) in Q3 2018, closing a stake of 33,728 shares — an estimated $1.16M sold.

Fuller & Thaler Asset Management first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $2.54M in Q1 2017. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

Fuller & Thaler Asset Management reported no remaining Pfizer position as of Q3 2018 after selling out during the quarter.
Fuller & Thaler Asset Management sold 33,728 Pfizer shares in Q3 2018, an estimated $1.16M.
Fuller & Thaler Asset Management first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
Fuller & Thaler Asset Management's Pfizer position peaked at $2.54M in Q1 2017.
2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.